As many different genetic alterations in chondrosarcoma have been identified, it is of the
utmost importance to classify druggable targets that may improve the prognosis of …

Introduction Dedifferentiated chondrosarcoma (DDC) is an aggressive osseous neoplasm
with a dismal prognosis. Treatment commonly involves limb-salvage surgery or amputation …

Background Dedifferentiated chondrosarcoma (DCS) is a highly malignant variant that
portends a poor prognosis. Although factors such as clinico-pathological characteristics …

Clear cell, mesenchymal, and dedifferentiated chondrosarcoma are rare, cartilaginous
tumors with limited treatment options other than surgery. Conventional chondrosarcomas …

Chondrosarcoma are primary bone tumors that bear some relationship to the cartilage
phenotype. They can arise de novo (primary) or from a preexisting benign cartilage tumors …

Background Dedifferentiated chondrosarcoma remains a significant therapeutic challenge.
Studies performed to date have not identified efficacious chemotherapy regimens for this …

Background Dedifferentiated chondrosarcoma is a rare, poorly understood and often fatal
sarcoma that usually manifests as a high grade, non–cartilage-producing sarcoma …

Chondrosarcoma is the second most common primary bone tumor, with> 90% of cases
representing the primary conventional subtype. In addition to arising de novo, conventional …

Dedifferentiated chondrosarcomas are a rare and aggressive subtype of chondrosarcoma
with a bimorphic pattern on histopathology. Rib is a rare site of dedifferentiated …

Chondrosarcomas are a diverse group of malignant cartilaginous matrix-producing
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …